Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

<h4>Background</h4> <p>Renal transplant recipients (RTR) frequently develop complications relating to chronic immunosuppression. Identifying RTR who could safely reduce immunosuppression is therefore highly desirable. We hypothesized that “signatures” described in RTR who have sto...

Podrobná bibliografie
Hlavní autoři:	Bottomley, M, Chen, M, Fuggle, S, Harden, P, Wood, K
Médium:	Journal article
Jazyk:	English
Vydáno:	Lippincott, Williams and Wilkins 2016

Podobné jednotky

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
Autor: Ramon M. Rodriguez, a další
Vydáno: (2021-08-01)

Update on the long-term complications of renal transplantation.
Autor: Bottomley, M, a další
Vydáno: (2013)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
Autor: Bottomley, M, a další
Vydáno: (2022)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
Autor: Mysore K. Phanish, a další
Vydáno: (2020-03-01)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
Autor: Bittar, A, a další
Vydáno: (1990)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
Autor: Bottomley, MJ, a další
Vydáno: (2022)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Autor: Procter, J, a další
Vydáno: (2009)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
Autor: I G Rekhtina, a další
Vydáno: (2008-07-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
Autor: Matthew J. Bottomley, a další
Vydáno: (2022-07-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
Autor: Sh. R. Galeev, a další
Vydáno: (2020-07-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Autor: Procter, J, a další
Vydáno: (2009)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
Autor: Ratcliffe, P, a další
Vydáno: (1996)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
Autor: Alessandro C. Rosa, a další
Vydáno: (2023-10-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
Autor: Alfonso J. Rodriguez-Morales, a další
Vydáno: (2017-04-01)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
Autor: Bottomley, M
Vydáno: (2015)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
Autor: Katherine A. Barraclough, a další
Vydáno: (2011-01-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
Autor: Lally, A, a další
Vydáno: (2006)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
Autor: Rahbaninobar Mohammad, a další
Vydáno: (2004-09-01)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
Autor: Noa Scott, a další
Vydáno: (2023-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
Autor: Cvetković Tatjana, a další
Vydáno: (2015-01-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
Autor: Muduma G, a další
Vydáno: (2014-11-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
Autor: Iqbal A, a další
Vydáno: (2000-01-01)

Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.
Autor: Jacek Pliszczynski, a další
Vydáno: (2020-09-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
Autor: Brook, MO, a další
Vydáno: (2022)

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
Autor: Sofia Christakoudi, a další
Vydáno: (2020-08-01)

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature
Autor: Joyita Bharati, a další
Vydáno: (2021-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
Autor: Koen G. A. M. Hussaarts, a další
Vydáno: (2021-01-01)

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
Autor: Knight, S, a další
Vydáno: (2016)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
Autor: Kentaro Ide, a další
Vydáno: (2011-01-01)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients
Autor: Pengpeng Zhang, a další
Vydáno: (2021-05-01)

Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection
Autor: Amitabh Jha, a další
Vydáno: (2018-01-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
Autor: Susan Dutton, a další
Vydáno: (2022-04-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
Autor: Ohe, H, a další
Vydáno: (2011)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
Autor: Jade M Kozuch, a další
Vydáno: (2024-12-01)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
Autor: Catherine Zilberg, a další
Vydáno: (2022-05-01)

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
Autor: Andreas Krisl, a další
Vydáno: (2020-12-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
Autor: Dagmara Szypulska-Koziarska, a další
Vydáno: (2021-07-01)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
Autor: V. Ram Peddi, MD, a další
Vydáno: (2023-02-01)

Predictors of cancer risk in the long-term solid-organ transplant recipient.
Autor: Sherston, SN, a další
Vydáno: (2014)

Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Autor: Jennifer Felicia Scheel, a další
Vydáno: (2018-02-01)